Najat Khan, PhD
Chief Data Science Officer, Global Head, Strategy and Operations
Najat Khan, Ph.D., holds a unique combination of leadership roles at Janssen. As Chief Data Science Officer for R&D, Najat leads a team leveraging AI, machine learning, real-world data, and digital health across Janssen’s pharmaceutical pipeline. As Global Head of Strategy & Operations for R&D, Najat shapes Janssen’s R&D strategy, including pipeline decisions and strategic initiatives. This work advances the company’s mission of driving transformational innovation for patients and changing the trajectory of healthcare.
Prior to joining Janssen, Najat was a Partner at The Boston Consulting Group (BCG). Named on Endpoints News’ ’20 Under 40’ in 2022, she received her Ph.D. in Organic Chemistry from the University of Pennsylvania.
Prior to joining Janssen, Najat was a Partner at The Boston Consulting Group (BCG). Named on Endpoints News’ ’20 Under 40’ in 2022, she received her Ph.D. in Organic Chemistry from the University of Pennsylvania.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Speaker Spotlight
-
Junaid Bajwa, MD • Practicing Physician, UK’s National Health Service; Chief Medical Scientist
-
Marwan Fathallah • President & Global Chief Executive
-
Amir Kalali, MD • Co-Chair
-
Najat Khan, PhD • Chief Data Science Officer, Global Head, Strategy and Operations
-
Zak Kohane, PhD • Chair, Department of Biomedical Informatics
-
Armen Mkrtchyan, PhD • Senior Principal
-
David Mukanga, PhD, MPH • Deputy Director, Africa Regulatory Systems
-
June Raine, MD, MSc, FRCP • CEO, Medicines and Healthcare Products Regulatory Agency